Characterising the role of GAPDH and chain length in GBS pathogenicity
Files
File version
Author(s)
Primary Supervisor
Ulett, Glen C
Other Supervisors
Sullivan, Matthew J
Goh, Guan Kai Kelvin
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Group B Streptococcus (GBS) colonisation in pregnant women poses a risk of transmission to infants during childbirth, leading to invasive diseases. GBS or Streptococcus agalactiae glyceraldehyde 3-phosphate dehydrogenase (GAPDH), encoded by gapC, is a glycolytic enzyme associated with virulence and immune-mediated protection. However, the role of GAPDH in bacterial phagocytosis and colonisation of the female reproductive tract, a central host niche, is unknown. We generated an S. agalactiae mutant that over-expresses GAPDH (874391p gapC) from gapC using a constitutively active promoter and analysed the mutant in murine macrophage antibiotic protection assays and in virulence assays in vivo, using a colonisation model that is based on experimental infection of the reproductive tract in female mice. Over-expression of GAPDH in GBS did not significantly affect measures of phagocytic uptake compared to an empty vector control. In contrast, 874391pgapC showed a small but statistically significant attenuation for persistence in the reproductive tract of female mice during the chronic phase of infection (10-28 days post-inoculation) relative to the vector control. We conclude that GBS GAPDH elicits the production of multiple cytokines from human cells, and over-expression of GAPDH renders the bacterium more susceptible to host clearance in the female reproductive tract. [...]
Journal Title
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Thesis (PhD Doctorate)
Degree Program
Doctor of Philosophy
School
School of Pharmacy & Med Sci
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
The author owns the copyright in this thesis, unless stated otherwise.
Item Access Status
Note
Access the data
Related item(s)
Subject
Group B Streptococcus (GBS)
GAPDH
chain length
vaccine development